ASCO22: Breast cancer research by Meredith Regan, ScD | Dana-Farber Cancer Institute

Dana-Farber's Meredith Regan, ScD presents research looking at early treatment effects of adjuvant endocrine therapy for high-risk breast cancer at #ASCO22
Read more: http://ms.spr.ly/6054bjZRw